U.S. markets close in 2 hours 32 minutes

  • S&P 500

    4,234.62
    -49.12 (-1.15%)
     

  • Dow 30

    33,777.70
    -221.34 (-0.65%)
     

  • Nasdaq

    12,708.51
    -256.83 (-1.98%)
     

  • Russell 2000

    1,961.97
    -38.76 (-1.94%)
     

  • Crude Oil

    91.30
    +0.80 (+0.88%)
     

  • Gold

    1,763.00
    -8.20 (-0.46%)
     

  • Silver

    19.05
    -0.41 (-2.13%)
     

  • EUR/USD

    1.0044
    -0.0048 (-0.47%)
     

  • 10-Yr Bond

    2.9780
    +0.0980 (+3.40%)
     

  • GBP/USD

    1.1830
    -0.0103 (-0.86%)
     

  • USD/JPY

    136.8500
    +0.9880 (+0.73%)
     

  • BTC-USD

    21,531.81
    -1,865.57 (-7.97%)
     

  • CMC Crypto 200

    512.45
    -29.15 (-5.38%)
     

  • FTSE 100

    7,550.37
    +8.52 (+0.11%)
     

  • Nikkei 225

    28,930.33
    -11.77 (-0.04%)
     

UBS' Gupta Jain on RBI Rate Decision

Tanvee Gupta Jain, Chief India Economist at UBS Securities, discusses her outlook for RBI rate decision and Indian economy. She speaks with Rishaad Salamat and Juliette Saly on "Bloomberg Markets: Asia".

Recommended Stories

  • Liz Cheney Leaks Audio Contradicting Trump-Backed Rival’s Accusations

    Harriet Hageman says the Wyoming representative didn't actually concede after losing on Election Night, but Cheney has the receipts

  • Warren Buffett is Buying the Dip on These 5 Stocks

    In this article, we discuss the 5 stocks that Warren Buffett is buying on the dip. If you want to see more stocks in this selection, click Warren Buffett is Buying the Dip on These 3 Stocks. Berkshire Hathaway’s Warren Buffett went on a buying spree despite the turmoil in the global equity markets. In […]

  • Why StoneCo Stock Fell Hard Today

    Shares of StoneCo (NASDAQ: STNE), a cloud-based technology platform, plummeted Friday morning after the company reported its second-quarter results, which disappointed investors, and announced yet another shift to its management team. The company reported non-GAAP (adjusted) earnings of 0.25 Brazilian reals (equivalent to $0.05), which was an increase from a loss of 0.48 reals in the year-ago quarter, but was below Wall Street's consensus estimate of about 0.57 reals, or $0.11 per share. StoneCo's revenue in the quarter was 2.3 billion reals (about $442 million), 5% higher than the company's guidance, and up 275% from the year-ago quarter.

  • 3 Layoff Stocks That You Might Not Want to Lay Off From Buying Right Now

    A lot of surprising companies are paring back their payrolls lately. Some of them should bounce back soon.

  • Read Why Aeglea BioTherapeutics Shares Are Skyrocketing Today?

    The European Medicines Agency (EMA) has validated Aeglea BioTherapeutics Inc's (NASDAQ: AGLE) marketing application seeking approval for pegzilarginase for the treatment of Arginase 1 Deficiency (ARG1-D). Arginase deficiency is an inherited disorder that causes the amino acid arginine (a building block of proteins) and ammonia to accumulate gradually in the blood. Ammonia, formed when proteins are broken down in the body, is toxic if levels become too high. Related: Aeglea BioTherapeutics Shares

  • Axsome’s depression drug receives FDA approval

    Yahoo Finance's Brian Cheung discusses reports that a depression drug from Axsome Therapeutics has gotten FDA clearance.

  • US Mortgage Lenders Are Starting to Go Broke

    (Bloomberg) -- The US mortgage industry is seeing its first lenders go out of business after a sudden spike in lending rates, and the wave of failures that’s coming could be the worst since the housing bubble burst about 15 years ago. Most Read from BloombergXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesUS Mortgage Lenders Are Starting to Go BrokeCovid’s Harmful Effects on the Brain Reverberate Years LaterBiden's Ne

  • The Average 401(k) Balance by Age

    How much money people have put away for retirement naturally varies by age. See how your savings stack up.

  • Investors Heavily Search Verizon Communications Inc. (VZ): Here is What You Need to Know

    Verizon (VZ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

  • Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

    The past few weeks have been refreshing for Cathie Wood and fans of her style of growth stock investing. The CEO and co-founder of Ark Invest publishes the buys and sells of her firm's exchange-traded funds (ETFs) every market day, giving the public insight into her latest allocation strategies.

  • Here's Why Ford Motor Company (F) is a Strong Value Stock

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

  • Stoneco LTD (STNE) Q2 2022 Earnings Call Transcript

    Joining us today on the call, we have our CEO, Thiago Piau; and our chief strategy officer, Lia Matos. As we noted previously, following the partial sale of our stake in Banco Inter, we decided to stop adjusting the bond financial expenses in order to result from the second quarter onwards.

  • How a 20-year-old USC student netted $110m from a Bed Bath & Beyond stock dump at exactly the right time

    Jake Freeman cashed out his 6% stake in the meme stock after it exploded on Tuesday.

  • Cohen Makes Millions on Bed Bath & Beyond as Meme Traders Recoil

    (Bloomberg) -- Billionaire Ryan Cohen pocketed a $68.1 million profit from the sale of his stake in Bed Bath & Beyond Inc., scoring a 56% gain on an investment he held for roughly seven months.Most Read from BloombergXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesUS Mortgage Lenders Are Starting to Go BrokeCovid’s Harmful Effects on the Brain Reverberate Years LaterBiden's Next Grand Bargain Could Retire TrumpThe ret

  • Top 10 Stock Picks of Osman Ozsan’s Deuterium Capital Management

    In this article, we will take a look at the top 10 stock picks of Osman Ozsan’s Deuterium Capital Management. If you want to skip our discussion of Deuterium Capital Management’s history, investment philosophy, and hedge fund preference, go directly to Top 5 Stock Picks of Osman Ozsan’s Deuterium Capital Management. Deuterium Capital Management, LLC […]

  • Bed Bath & Beyond stock crashes after Ryan Cohen exit

    Yahoo Finance Live anchors discuss Bed Bath & Beyond stock performance after activist investor Ryan Cohen completes his sale of shares.

  • Why Axsome Therapeutics Stock Is Crushing It Today

    The stock price of the specialist in central nervous system disorders is shooting higher today in response to the Food and Drug Administration's (FDA) approval of its major depressive disorder (MDD) drug Auvelity. Auvelity has been under review with the FDA for well over a year at this point. The drug's review took longer than expected due to issues with the analytical methods in the Chemistry, Manufacturing, and Controls section of its regulatory application.

  • Massive Short Squeeze Behind Stock Rally Showing Signs of Ending

    (Bloomberg) -- One big force at the center of the two-month equity rally is showing signs of fatigue. Most Read from BloombergXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesUS Mortgage Lenders Are Starting to Go BrokeCovid’s Harmful Effects on the Brain Reverberate Years LaterBiden's Next Grand Bargain Could Retire TrumpIt’s the behavior of short sellers, whose frantic efforts to unwind bearish wagers created buying

  • College Costs: How the US Stacks Up to Other Countries

    It is well-known that the cost of college has been increasing in the U.S., typically much faster than inflation. Although the rate of inflation has been higher recently, it tends to be around 2%....

  • Investors Heavily Search MercadoLibre, Inc. (MELI): Here is What You Need to Know

    MercadoLibre (MELI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.